| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT06581406 | A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in… | Metastatic Uveal Melanoma | Recruiting |
| Phase 2 | |||
| NCT05733598 | Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or… | Hepatocellular Carcinoma | Recruiting |
| NCT03767348 | Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) | Non-Small Cell Lung Cancer (NSCLC) | Active, Not Recruiting |
| Phase 1 | |||
| NCT04336241 | Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid… | Cancer | Active, Not Recruiting |
| NCT04735978 | Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid… | Advanced Solid Tumor | Active, Not Recruiting |
| Not specified | |||
| NCT06887348 | A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1… | Melanoma | Recruiting |